Banque Cantonale Vaudoise - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
Banque Cantonale Vaudoise ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20
-25.9%
15,0000.0%0.00%0.0%
Q2 2023$27
-53.4%
15,0000.0%0.00%
-66.7%
Q1 2023$58
-65.9%
15,000
+175.2%
0.00%
-66.7%
Q4 2022$170
-99.9%
5,4500.0%0.01%
-43.8%
Q3 2022$274,000
+21.2%
5,4500.0%0.02%
+33.3%
Q2 2022$226,000
-38.6%
5,4500.0%0.01%
-25.0%
Q1 2022$368,000
+161.0%
5,450
+2377.3%
0.02%
+220.0%
Q4 2021$141,000
-66.3%
220
-99.6%
0.01%
-73.7%
Q3 2021$419,000
+35.2%
50,220
+151.1%
0.02%
+11.8%
Q4 2020$310,000
+6.2%
20,0000.0%0.02%
-10.5%
Q3 2020$292,00020,0000.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders